B-cell Acute Lymphoblastic Leukemia (B-ALL) research hub
3 indexed studies · 2 currently recruiting
- recruitingPHASE1, PHASE2
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
This study is testing a new medicine, AZD4512, for B-cell Acute Lymphoblastic Leukaemia (B-ALL) in people whose cancer has come back or not responded to other treatments. Researchers want to see if it's safe and how well it works.
United States · Australia · Canada - active not recruitingPHASE1
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
This study is testing a new medicine called PIT565 for people in the UK with certain types of blood cancer (B-cell Non-Hodgkin Lymphoma and B-cell Acute Lymphoblastic Leukaemia) that haven't responded well to previous treatments. It aims to find a safe dose and see how it works.
United States · Belgium · China - recruitingPHASE1, PHASE2
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
This study is testing a new medicine called AZD0486 for people with a type of blood cancer called B-cell Acute Lymphoblastic Leukaemia (B-ALL). It aims to find out if it's safe, what dose works best, and if it can help fight the cancer when other treatments haven't worked.
United States · Australia · Brazil